Welcome international healthcare professionals

Welcome, this website is intended for healthcare professionals with an interest in the treatment of Melanoma. By clicking the button below you are declaring and confirming that you are a healthcare professional.

Welcome to the European Journal of Cancer’s Advances in Melanoma Resource Centre.

The Resource Centre, edited by Prof. Reinhard Dummer, Dr. Paolo Ascierto and Dr. James Larkin, will provide you with the latest research on melanoma, including a selection of original research and review articles from some of the world’s leading journals, case studies, and...

Paper of the month – May 2015

  • Pembrolizumab versus Ipilimumab in Advanced Melanoma

    Caroline Robert, M.D., Ph.D., Jacob Schachter, M.D., Georgina V. Long, M.D., Ph.D., Ana Arance, M.D., Ph.D., Jean Jacques Grob, M.D., Ph.D., Laurent Mortier, M.D., Ph.D., Adil Daud, M.D. et al.

    Background The immune checkpoint inhibitor ipilimumab is the standard-of-care treatment for patients with advanced melanoma. Pembrolizumab inhibits the programmed cell...

    Editors’ comment: Dr. Paolo Ascierto
    Immunotherapy represents one of the fastest growing areas in oncology. The two main inhibitory...

Latest articles

About the editors





Register to our E-Alert to stay informed of new clinical research and cases published on this platform.

Event planner

Featured videos

Watch the videos from Reinhard Dummer, Dirk Schadendorf, Veronique del Marmol and Christian Blank.

Search this site

Search form